Dexcom

Dexcom is a medical device company specialising in continuous glucose monitoring systems for people with diabetes. Its sensors and wearable devices let users track blood sugar in real time without routine finger-prick tests, and the shift toward continuous monitoring has driven rapid, recurring revenue growth as the technology reaches a broader patient base. Dexcom pays no dividend, reinvesting its cash into research, manufacturing capacity and international expansion. This is a growth-oriented medical technology company, and its low score reflects the absence of any distribution. The investment case rests on continued adoption of continuous glucose monitoring rather than on income.